• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

加速失效时间模型的开发和验证,用于口腔鳞状细胞癌的特定原因生存和预后预测:SEER 数据分析。

Development and validation of accelerated failure time model for cause-specific survival and prognostication of oral squamous cell carcinoma: SEER data analysis.

机构信息

Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio, United States of America.

Department of Oral and Maxillofacial Surgery, University of Port Harcourt, Choba, Nigeria.

出版信息

PLoS One. 2024 Aug 26;19(8):e0309214. doi: 10.1371/journal.pone.0309214. eCollection 2024.

DOI:10.1371/journal.pone.0309214
PMID:39186725
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11346929/
Abstract

BACKGROUND

Oral Squamous Cell Carcinoma is the most prevalent malignancies affecting the oral cavity. Despite progress in studies and treatment options its outlook remains grim with survival prospects greatly affected by demographic and clinical factors. Precisely predicting survival rates and prognosis plays a role in making treatment choices for the best achievable overall health outcomes.

OBJECTIVE

To develop and validate an accelerated failure time model as a predictive model for cause-specific survival and prognosis of Oral Squamous Cell Carcinoma patients and compare its results to the traditional Cox proportional hazard model.

METHOD

We screened Oral cancer patients diagnosed with Squamous Cell Carcinoma from the Surveillance Epidemiology and End Results (SEER) database between 2010 and 2020. An accelerated failure time model using the Type I generalized half logistic distribution was used to determine independent prognostic factors affecting the survival time of patients with oral squamous carcinoma. In addition, accelerated factors were estimated to assess how some variables influence the survival times of the patients. We used the Akaike Information Criterion, Bayesian Information Criterion to evaluate the model fit, the area under the curve for discriminability, Concordance Index (C-index) and Root Mean Square Error and calibration curve for predictability, to compare the type I generalized half logistic survival model to other common classical survival models. All tests are conducted at a 0.05 level of significance.

RESULTS

The accelerated failure time models demonstrated superior effectiveness in modeling (fit and predictive accuracy) the cause-specific survival (CSS) of oral squamous cell carcinoma compared to the Cox model. Among the accelerated failure time models considered, the Type I generalized half logistic distribution exhibited the most robust model fit, as evidenced by the lowest Akaike Information Criterion (AIC = 27370) and Bayesian Information Criterion (BIC = 27415) values. This outperformed other parametric models and the Cox Model (AIC = 47019, BIC = 47177). The TIGHLD displayed an AUC of 0.642 for discrimination, surpassing the Cox model (AUC = 0.544). In terms of predictive accuracy, the model achieved the highest concordance index (C-index = 0.780) and the lowest root mean square error (RMSE = 1.209), a notable performance over the Cox model (C-index = 0.336, RMSE = 6.482). All variables under consideration in this study demonstrated significance at the 0.05 level for CSS, except for race and the time span from diagnosis to treatment, in the TIGHLD AFT model. However, differences emerged regarding the significant variations in survival times among subgroups. Finally, the results derived from the model revealed that all significant variables except chemotherapy, all TNM stages and patients with Grade II and III tumor presentations contributed to the deceleration of time to cause-specific deaths.

CONCLUSIONS

The accelerated failure time model provides a relatively accurate method to predict the prognosis of oral squamous cell carcinoma patients and is recommended over the Cox PH model for its superior predictive capabilities. This study also underscores the importance of using advanced statistical models to improve survival predictions and outcomes for cancer patients.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19c3/11346929/78c7aeae9733/pone.0309214.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19c3/11346929/9dabf09eb95e/pone.0309214.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19c3/11346929/18cd0e6529d2/pone.0309214.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19c3/11346929/78c7aeae9733/pone.0309214.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19c3/11346929/9dabf09eb95e/pone.0309214.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19c3/11346929/18cd0e6529d2/pone.0309214.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19c3/11346929/78c7aeae9733/pone.0309214.g003.jpg
摘要

背景

口腔鳞状细胞癌是最常见的影响口腔的恶性肿瘤。尽管在研究和治疗方案方面取得了进展,但由于人口统计学和临床因素的影响,其预后仍然严峻,生存前景受到极大影响。准确预测生存率和预后对于为实现最佳整体健康结果选择治疗方案至关重要。

目的

开发并验证加速失效时间模型作为口腔鳞状细胞癌患者的特定原因生存和预后的预测模型,并将其结果与传统的 Cox 比例风险模型进行比较。

方法

我们从 2010 年至 2020 年期间的监测、流行病学和最终结果(SEER)数据库中筛选出诊断为鳞状细胞癌的口腔癌患者。使用 I 型广义半对数分布的加速失效时间模型来确定影响口腔鳞状细胞癌患者生存时间的独立预后因素。此外,还估计了加速因素,以评估某些变量如何影响患者的生存时间。我们使用赤池信息量准则、贝叶斯信息量准则来评估模型拟合度、区分曲线下面积、一致性指数(C 指数)和均方根误差和校准曲线来预测,以比较 I 型广义半对数生存模型与其他常见的经典生存模型。所有检验均在 0.05 水平上进行。

结果

与 Cox 模型相比,加速失效时间模型在建模(拟合和预测准确性)口腔鳞状细胞癌的特定原因生存(CSS)方面表现出更好的效果。在所考虑的加速失效时间模型中,I 型广义半对数分布表现出最稳健的模型拟合,证据是最低的赤池信息量准则(AIC = 27370)和贝叶斯信息量准则(BIC = 27415)值。这优于其他参数模型和 Cox 模型(AIC = 47019,BIC = 47177)。TIGHLD 的区分度 AUC 为 0.642,超过了 Cox 模型(AUC = 0.544)。在预测准确性方面,该模型的一致性指数(C 指数)最高(C 指数 = 0.780),均方根误差(RMSE)最低(RMSE = 1.209),明显优于 Cox 模型(C 指数 = 0.336,RMSE = 6.482)。在 TIGHLD AFT 模型中,除种族和诊断到治疗的时间间隔外,所有纳入本研究的变量在 CSS 方面均具有统计学意义(p 值均 < 0.05)。然而,在亚组间生存时间的显著变化方面存在差异。最后,模型得出的结果表明,除化疗、所有 TNM 分期和 II 级和 III 级肿瘤表现的患者外,所有有意义的变量都有助于特定原因死亡时间的减速。

结论

加速失效时间模型为口腔鳞状细胞癌患者的预后提供了一种相对准确的预测方法,并且因其预测能力更强,建议优先选择 Cox PH 模型。本研究还强调了使用先进的统计模型来提高癌症患者生存预测和结果的重要性。

相似文献

1
Development and validation of accelerated failure time model for cause-specific survival and prognostication of oral squamous cell carcinoma: SEER data analysis.加速失效时间模型的开发和验证,用于口腔鳞状细胞癌的特定原因生存和预后预测:SEER 数据分析。
PLoS One. 2024 Aug 26;19(8):e0309214. doi: 10.1371/journal.pone.0309214. eCollection 2024.
2
An Accelerated Failure Time Model to Predict Cause-Specific Survival and Prognostic Factors of Lung and Bronchus Cancer Patients with at Least Bone or Brain Metastases: Development and Internal Validation Using a SEER-Based Study.一种加速失效时间模型,用于预测至少有骨转移或脑转移的肺癌和支气管癌患者的特定病因生存率及预后因素:基于监测、流行病学和最终结果(SEER)研究的模型开发与内部验证
Cancers (Basel). 2024 Feb 4;16(3):668. doi: 10.3390/cancers16030668.
3
Prognostic value of lymph node metrics in lung squamous cell carcinoma: an analysis of the SEER database.肺鳞状细胞癌中淋巴结指标的预后价值:基于监测、流行病学和最终结果(SEER)数据库的分析
World J Surg Oncol. 2024 Dec 28;22(1):351. doi: 10.1186/s12957-024-03639-4.
4
Constructing a prognostic model for colorectal cancer with synchronous liver metastases after preoperative chemotherapy: a study based on SEER and an external validation cohort.基于 SEER 和外部验证队列构建术前化疗后结直肠癌伴肝转移的预后模型: 一项研究。
Clin Transl Oncol. 2024 Dec;26(12):3169-3190. doi: 10.1007/s12094-024-03513-5. Epub 2024 Jun 4.
5
A nomogram for predicting cancer-specific survival in patients with locally advanced unresectable esophageal cancer: development and validation study.预测局部晚期不可切除食管癌患者癌症特异性生存的列线图:开发与验证研究
Front Immunol. 2025 Feb 14;16:1524439. doi: 10.3389/fimmu.2025.1524439. eCollection 2025.
6
Development of a Nomogram-Based Online Calculator for Predicting Cancer-Specific Survival in Patients With Digestive Tract Mixed Neuroendocrine-Non-Neuroendocrine Neoplasms (MiNENs): An Analysis of the SEER Database.基于列线图的在线计算器的开发,用于预测消化道混合性神经内分泌-非神经内分泌肿瘤(MiNENs)患者的癌症特异性生存率:监测、流行病学和最终结果(SEER)数据库分析
Cancer Rep (Hoboken). 2025 Feb;8(2):e70156. doi: 10.1002/cnr2.70156.
7
Establishment of a Prognostic Nomogram for Cancer-Specific Survival in Patients With Base-of-Tongue Squamous Cell Carcinoma: A Retrospective Study Based on the SEER Database.基于 SEER 数据库的回顾性研究:建立预测舌底鳞癌患者癌症特异性生存的预后列线图。
Cancer Control. 2023 Jan-Dec;30:10732748231210733. doi: 10.1177/10732748231210733.
8
Nomogram forecasting 3-, 5-, and 8-year overall survival and cancer-specific survival of gingival squamous cell carcinoma.列线图预测牙龈鳞状细胞癌的 3、5 和 8 年总生存和癌症特异性生存。
Cancer Med. 2020 Nov;9(21):8266-8274. doi: 10.1002/cam4.3436. Epub 2020 Sep 22.
9
A nomogram to predict postoperative overall and cancer specific survival in patients with primary parotid squamous cell carcinoma: a population based study.预测原发性腮腺鳞状细胞癌患者术后总体生存率和癌症特异性生存率的列线图:一项基于人群的研究。
Sci Rep. 2025 Feb 25;15(1):6774. doi: 10.1038/s41598-025-90480-8.
10
Development and validation of a nomogram for predicting cancer-specific survival in small-bowel adenocarcinoma patients using the SEER database.基于 SEER 数据库的列线图模型构建与验证:用于预测小肠腺癌患者癌症特异性生存的研究。
World J Surg Oncol. 2024 Jun 7;22(1):151. doi: 10.1186/s12957-024-03438-x.

本文引用的文献

1
An Accelerated Failure Time Model to Predict Cause-Specific Survival and Prognostic Factors of Lung and Bronchus Cancer Patients with at Least Bone or Brain Metastases: Development and Internal Validation Using a SEER-Based Study.一种加速失效时间模型,用于预测至少有骨转移或脑转移的肺癌和支气管癌患者的特定病因生存率及预后因素:基于监测、流行病学和最终结果(SEER)研究的模型开发与内部验证
Cancers (Basel). 2024 Feb 4;16(3):668. doi: 10.3390/cancers16030668.
2
A prognostic model for oral squamous cell carcinoma patients with type 2 diabetes mellitus.2 型糖尿病口腔鳞状细胞癌患者的预后模型。
Arch Oral Biol. 2023 Aug;152:105735. doi: 10.1016/j.archoralbio.2023.105735. Epub 2023 May 23.
3
Prognosis and Nomogram Prediction for Patients with Oral Squamous Cell Carcinoma: A Cohort Study.
口腔鳞状细胞癌患者的预后及列线图预测:一项队列研究
Diagnostics (Basel). 2023 May 17;13(10):1768. doi: 10.3390/diagnostics13101768.
4
A novel T-cell proliferation-associated gene predicts prognosis and reveals immune infiltration in patients with oral squamous cell carcinoma.一个新型的 T 细胞增殖相关基因可预测口腔鳞状细胞癌患者的预后并揭示免疫浸润情况。
Arch Oral Biol. 2023 Aug;152:105719. doi: 10.1016/j.archoralbio.2023.105719. Epub 2023 May 9.
5
A nomogram for predicting overall survival of patients with squamous cell carcinoma of the floor of the mouth: a population-based study.基于人群的研究:用于预测口底鳞状细胞癌患者总生存期的列线图。
Eur Arch Otorhinolaryngol. 2023 Aug;280(8):3867-3875. doi: 10.1007/s00405-023-07971-5. Epub 2023 Apr 18.
6
Epidemiology and incidence of oral squamous cell carcinoma in the Iraqi population over 5 years (2014-2018).伊拉克人群5年(2014 - 2018年)口腔鳞状细胞癌的流行病学及发病率
Health Sci Rep. 2023 Apr 11;6(4):e1205. doi: 10.1002/hsr2.1205. eCollection 2023 Apr.
7
RAN and YBX1 are required for cell proliferation and IL-4 expression and linked to poor prognosis in oral squamous cell carcinoma.RAN 和 YBX1 是口腔鳞状细胞癌细胞增殖和 IL-4 表达所必需的,与不良预后相关。
Exp Cell Res. 2021 Sep 15;406(2):112767. doi: 10.1016/j.yexcr.2021.112767. Epub 2021 Aug 5.
8
Nomograms to predict the prognosis in locally advanced oral squamous cell carcinoma after curative resection.预测根治性切除术后局部晚期口腔鳞状细胞癌预后的列线图。
BMC Cancer. 2021 Apr 7;21(1):372. doi: 10.1186/s12885-021-08106-x.
9
Clinical characteristics, treatment methods and prognoses of patients with oral squamous cell carcinoma in Japanese population: a single institution retrospective cohort study.日本人群口腔鳞状细胞癌患者的临床特征、治疗方法及预后:一项单机构回顾性队列研究
BMC Geriatr. 2020 Nov 20;20(1):487. doi: 10.1186/s12877-020-01902-3.
10
Parametric survival model to identify the predictors of breast cancer mortality: An accelerated failure time approach.用于识别乳腺癌死亡率预测因素的参数生存模型:一种加速失效时间方法。
J Res Med Sci. 2020 Apr 13;25:38. doi: 10.4103/jrms.JRMS_743_19. eCollection 2020.